Eli Lilly and Princeton University are suing generic drugmaker Barr Laboratories in a federal court for allegedly infringing a US patent owned by Princeton and exclusively licensed to Lilly as the basis for its blockbuster lung cancer chemotherapeutic Alimta.

The suit is the third filed by co-plaintiffs Lilly and Princeton against generic drug makers looking to manufacture a knock-off of the drug prior to the patent's expiration in an effort to protect their interest in a compound that generated more than $1 billion in revenues last year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.